Cargando…
Lipidomic and Metabolomic Signature of Progression of Chronic Kidney Disease in Patients with Severe Obesity
Severe obesity is a major risk for chronic kidney disease (CKD). Early detection and careful monitoring of renal function are critical for the prevention of CKD during obesity, since biopsies are not performed in patients with CKD and diagnosis is dependent on the assessment of clinical parameters....
Autores principales: | Lanzon, Borja, Martin-Taboada, Marina, Castro-Alves, Victor, Vila-Bedmar, Rocio, González de Pablos, Ignacio, Duberg, Daniel, Gomez, Pilar, Rodriguez, Elias, Orešič, Matej, Hyötyläinen, Tuulia, Morales, Enrique, Ruperez, Francisco J., Medina-Gomez, Gema |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8707539/ https://www.ncbi.nlm.nih.gov/pubmed/34940593 http://dx.doi.org/10.3390/metabo11120836 |
Ejemplares similares
-
Lipidomic Analyses Reveal Modulation of Lipid Metabolism by the PFAS Perfluoroundecanoic Acid (PFUnDA) in Non-Obese Diabetic Mice
por: Hyötyläinen, Tuulia, et al.
Publicado: (2021) -
Renoprotective role of bariatric surgery in patients with established chronic kidney disease
por: Morales, Enrique, et al.
Publicado: (2020) -
Novel Insights in the Physiopathology and Management of Obesity-Related Kidney Disease
por: Sandino, Justo, et al.
Publicado: (2022) -
Exposure to persistent organic pollutants alters the serum metabolome in non-obese diabetic mice
por: Sinioja, Tim, et al.
Publicado: (2022) -
Dynamics of the Lipidome in a Colon Simulator
por: Kråkström, Matilda, et al.
Publicado: (2023)